· Intro
· List of drugs
· Table: genotype, phenotype, frequency, effect
Nature |
· Microsomal enzyme · Mostly in liver |
Function |
· Redox (especially O-demethylation) |
Importance |
· Affects 25% of clinically used drugs |
Allelic variants |
· |
Problem |
· Polymorphism is common · Non-inducible enzyme |
Activated (i.e. prodrugs) |
· Codeine -> morphine (↑↑potency) · Tramadol -> M1 (4 x analgesic efficacy, 200x MOP affinity) · Oxycodone -> oxymorphone (10-15x ↑potency) · Tamoxifen |
Inactivated |
· Antidepressants (SSRIs, TCAs) · Antipsychotics (haloperidol, risperidone) · Metoprolol · Clonidine |
Allelic variants |
· ‘Normal’ (1,2) · ‘Reduced activity’ (9,10,41) · ‘No activity’ (4,5,6) |
Phenotypes |
By number of ‘Normal’ copies: · Ultra-rapid: >2 · Extensive: 2 (i.e. usual) · Intermediate: 1 (or 2x ‘Reduced activity’) · Poor: 0 |
Prevalence |
· Ultra-rapid: 30% Nth Africa, Arabs; 10% Greek/Portuguese; 1-3% others · Extensive: 80-90% · Intermediate: 2-10% · Poor: 5-10% Caucasians, 30% Hong Kong Chinese |
Drug activated |
· ↑Peak effect, ↑toxicity · ↑Duration · e.g. codeine toxicity (N.B. if given to UM mother -> neonatal fatality) |
Drug inactivated |
· ↓Peak effect · ↓Duration · e.g. clonidine effective shortened (?) |
Drug activated |
· ↓Peak effect · ↓Duration · e.g. codeine and tramadol ineffective |
Drug inactivated |
· ±↑Peak effect, +/- ↑toxicity · ↑Duration · e.g. clonidine effect prolonged (?) |
Feedback welcome at ketaminenightmares@gmail.com